GP leaders are warning that nearly 3.5 million patients are at risk of losing their family doctor, if the status of doctors from the European Union is not protected during
On May 22, 2017, the European Medicines Agency (EMA) announced that its Pharmacovigilance Risk Assessment Committee has completed an audit and evaluation of the new EudraVigilance information system for tracking
Even before European officials present the groundwork for relocating the bloc’s drug regulator, a fight has emerged between countries vying for the economic lift and status that come with hosting the
The State Patent Bureau of the Republic of Lithuania (SPB) and Kaunas University of Technology National Innovation and Entrepreneurship Centre (KTU NIEC)has signed the collaboration agreement, which laid foundation for
Recordati announced that it has entered into an agreement with AstraZeneca for the acquisition of the rights to Seloken®/Seloken® ZOK (metoprolol succinate) and associated Logimax® fixed dose combination (metoprolol succinate
Hansa Medical has accessed the EMA’s priority medicines scheme to accelerate the development of a therapy that broadens the access to kidney transplants. Hansa Medical, based in Lund, Sweden, develops
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval to expand the use of Novartis’ Zykadia (ceritinib) in anaplastic lymphoma kinase (ALK)-positive non-small cell
Veltassa (patiromer), developed by Relypsa, has received a recommendation for marketing approval from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for the
Aspen Pharmacare is under investigation by the European Commission over its pricing practices for five cancer medicines. EU antitrust regulators will investigate whether the South African generics firm abused
Fewer than two in 10 medicines exceed the average pharmaceutical R&D cost required to bring a drug to market when the risks of failure to reach market approval are factored
Cinfa Biotech announced trial results for a biosimilar of Amgen’s Neulasta, a multi-billion blockbuster to treat chemotherapy-induced neutropenia. Cinfa Biotech is a Spanish company specialized in developing biosimilars. The biotech
The German pharmaceuticals market is set to rise from $67.9 billion (€52.9 billion) in 2016 to around $86.3 billion (€67.2 billion) in 2021, representing a compound annual growth rate
From diagnosis of HIV to successful viral suppression: this new ECDC report summarises key findings concerning and the Continuum of HIV Care in Europe based on data reported by countries
The European Medicines Agency’s (EMA) 2016 annual report focuses on the Agency’s key achievements in the areas of medicine evaluation, support to research and development of new and innovative treatments and
Ireland has stepped up its bid to host the European Medicines Agency (EMA) with the official announcement being delivered and reiterated by Minister of Health, Simon Harris over the past
This year’s advisory board for CPhI Worldwide has been announced by organiser, UBM EMEA. Featuring five new global experts, the board will help shape the agenda of the CPhI Worldwide
Ashfield Healthcare Communications, a global healthcare communications agency, announces significant growth across the UK and Europe. Ashfield Healthcare Communications has a new presence in Dublin, Ireland, joining the office of
Abbott (NYSE: ABT) today announced CE Mark and first use of the new Confirm RxTM Insertable Cardiac Monitor (ICM), the world’s first smartphone compatible ICM that will help physicians identify
A self-cleaning keyboard which claims to eliminate 99.99% of bacteria and pathogens has been developed by technology company Vioguard. The keyboard comes with its own case which acts as the
EMA and the European Commission released a biosimilars information guide for health professionals during the EC’s biosimilars conference. In an effort to provide healthcare professionals with information on the science
On May 2, 2017, the EMA and European Commission published a notice alerting Marketing Authorization Holders of centrally authorized medicines of their obligations in relation to Brexit. Although the final
The European Commission has published the in vitro diagnostic medical device Regulation (IVDR) and the medical device Regulation (MDR). The
Spain’s pharmaceutical market set to show signs of stability, surpassing $25 billion by 2021, says GlobalData. The Spanish pharmaceutical market
A late stage clinical study of Aeterna Zentaris’ Zoptrex in women with locally advanced, recurrent or metastatic endometrial cancer has
On 4 May, the in vitro diagnostic medical device industry will gather in Dublin for an All-Ireland IVD Symposium on
EU regulators have expanded the scope of Janssen’s Darzalex to include patients with multiple myeloma who have received at least
This growth is across the nine major countries of the US, France, Germany, Italy, Spain, the UK, Japan, Brazil and
Intuitive Surgical has bagged a CE mark for the latest product in its da Vinci series of robot-assisted surgical systems.
After Danish and Swedish, Solidsoft Reply, the Reply group company specialising in enterprise strength solutions on the Microsoft Azure cloud
This year’s Med-Tech Innovation Expo will see 3D printing and additive manufacturing group Stratasys demonstrate how its advanced 3D printing
Pharmaceutical wholesaler United Drug has announced a €40 million investment in technology and innovation at its headquarters at Citywest in
Inoviem Scientific, a contract research biotech (CRB), has secured funding of €750k from existing financial partners to support the company’s
Smart bandages that can detect how a wound is healing and send messages back doctors could be trialled within the
On April 18, 2017 Fujifilm announced the completion of a $93-million cGMP production facility in Texas. The facility expansion is
This year’s Medtec Europe showed a record attendance with a 7% increase in overall visits. The event attracted 6,816 attendees
Irish medtech firm Diaceutics is set to add 30 jobs to its workforce in the coming year, as the company
With Brexit centre stage, there is a temptation for all attention in Ireland to focus on two topics: how much
The medtech sector has welcomed the vote from the European Parliament to endorse new regulations on in vitro diagnostic medical
A new government report shows that digital health companies in the UK generated a turnover of over £1 billion in
Contrary to some political claims, the U.S. Food and Drug Administration approved more drugs, and two to three months faster on average, than
Amryt Pharma, the orphan drug development company that was subject to a reverse takeover of former oil and gas group
Now that the die has been cast, it’s time for the deal-making process to begin – if indeed a deal
Sharp Clinical Services, part of UDG Healthcare plc, has announced a £9 million ($11.2 million) investment to fund a new multiple-phase pharmaceutical
The European Medicines Agency (EMA) wants to suspend around 300 marketed generic meds (and applications) coming out of Indian CRO
Zika virus (ZIKV), which causes Zika virus disease, is spread to people primarily through the bite of an infected Aedes aegypti or Aedes
The agency is recommending the suspension of a variety of medications because of unreliable bioequivalence studies conducted by Micro Therapeutic
A new study published in PLOS Medicine’s Special Issue on Dementia has found that the metabolism of omega-3 and
Drugmaker Mylan has recalled over 80,000 EpiPens across the world due to reports of the device failing to activate. The
The move by Great Britain to step away from the European Union may be sending chills of uncertainty to many
Merck, a leading science and technology company, announced today the new startups participating in its Accelerator programs in Darmstadt, Germany
Eurofins Scientific announced on March 20, 2017 that it will be establishing a new pharmaceutical chemistry and microbiology facility in